Abstract
Although advances in immunosuppression and antimicrobial prophylaxis have led to improved patient and graft survival, respiratory viruses continue to be a common cause of morbidity and mortality in immunocompromised populations. We describe the clinical manifestations, diagnosis and treatment options for influenza, respiratory syncytial virus and adenovirus infection in the kidney transplant population.
Keywords:
influenza virus; kidney transplant; respiratory syncytial virus.
Copyright © 2016 Elsevier Inc. All rights reserved.
Publication types
-
Review
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adenovirus Infections, Human / chemically induced*
-
Adenovirus Infections, Human / diagnosis
-
Adenovirus Infections, Human / therapy
-
Antiviral Agents / therapeutic use
-
Graft Rejection / prevention & control*
-
Humans
-
Immunosuppressive Agents / adverse effects*
-
Influenza Vaccines / therapeutic use
-
Influenza, Human / chemically induced*
-
Influenza, Human / diagnosis
-
Influenza, Human / prevention & control
-
Influenza, Human / therapy
-
Kidney Failure, Chronic / surgery*
-
Kidney Transplantation*
-
Respiratory Syncytial Virus Infections / chemically induced*
-
Respiratory Syncytial Virus Infections / diagnosis
-
Respiratory Syncytial Virus Infections / therapy
-
Respiratory Tract Infections / chemically induced*
-
Respiratory Tract Infections / diagnosis
-
Respiratory Tract Infections / therapy
Substances
-
Antiviral Agents
-
Immunosuppressive Agents
-
Influenza Vaccines